Tibor Gajdics
Directeur/Membre du Conseil chez GOLDEN AGE EXPLORATION LTD.
Fortune : 48 501 $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Kevin Hanson | M | 67 | 8 ans | |
| Ian Hollis Mann | M | 66 |
KOP Therapeutics Corp.
 KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 12 ans |
| Angela Holowaychuk | F | 41 | 6 ans | |
| Mark Redcliffe | M | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
| Ehsan Salmabadi | M | 41 | 2 ans | |
| Aziz-Ur Rehman | M | 51 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 3 ans |
| Marco Strub | M | 68 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
| Jakson Inwentash | M | 30 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 2 ans |
| Joyce Heinzerling Davis | F | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 5 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Simon Moore | M | - | - | |
| Chrisilios Kyriakou | M | 70 | - | |
| Garry Stock | M | - | 1 ans | |
| Garry Stock | M | 56 | 1 ans | |
| David Rokoss | M | - | - | |
| Owen C. King | M | - | 1 ans | |
| Andrew Wilkins | M | 64 | - | |
| Emma Fairhurst | F | - | - | |
| Rich Wheeless | M | - | - | |
| Peter Wielgosz | M | - | - | |
| Justin Corinella | M | - | 1 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Canada | 20 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Tibor Gajdics
- Réseau Personnel
